233 related articles for article (PubMed ID: 21266983)
21. Blood levels of glutamate oxaloacetate transaminase are more strongly associated with good outcome in acute ischaemic stroke than glutamate pyruvate transaminase levels.
Campos F; Rodríguez-Yáñez M; Castellanos M; Arias S; Pérez-Mato M; Sobrino T; Blanco M; Serena J; Castillo J
Clin Sci (Lond); 2011 Jul; 121(1):11-7. PubMed ID: 21265738
[TBL] [Abstract][Full Text] [Related]
22. The neuroprotective effects of oxaloacetate in closed head injury in rats is mediated by its blood glutamate scavenging activity: evidence from the use of maleate.
Zlotnik A; Gruenbaum SE; Artru AA; Rozet I; Dubilet M; Tkachov S; Brotfain E; Klin Y; Shapira Y; Teichberg VI
J Neurosurg Anesthesiol; 2009 Jul; 21(3):235-41. PubMed ID: 19543002
[TBL] [Abstract][Full Text] [Related]
23. Quercetin Attenuates Decrease of Thioredoxin Expression Following Focal Cerebral Ischemia and Glutamate-induced Neuronal Cell Damage.
Park DJ; Kang JB; Shah FA; Jin YB; Koh PO
Neuroscience; 2020 Jan; 428():38-49. PubMed ID: 31874239
[TBL] [Abstract][Full Text] [Related]
24. Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas.
Ruban A; Berkutzki T; Cooper I; Mohar B; Teichberg VI
Invest New Drugs; 2012 Dec; 30(6):2226-35. PubMed ID: 22392507
[TBL] [Abstract][Full Text] [Related]
25. Spatio-temporal assessment of the neuroprotective effects of neuregulin-1 on ischemic stroke lesions using MRI.
Wang S; Li Y; Paudyal R; Ford BD; Zhang X
J Neurol Sci; 2015 Oct; 357(1-2):28-34. PubMed ID: 26183085
[TBL] [Abstract][Full Text] [Related]
26. Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates.
Suzuki N; Suzuki M; Murakami K; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2012 Jan; 1430():93-100. PubMed ID: 22119394
[TBL] [Abstract][Full Text] [Related]
27. The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia.
Li DJ; Li YH; Yuan HB; Qu LF; Wang P
Metabolism; 2017 Mar; 68():31-42. PubMed ID: 28183451
[TBL] [Abstract][Full Text] [Related]
28. Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats.
Zuo G; Zhang D; Mu R; Shen H; Li X; Wang Z; Li H; Chen G
Mol Brain; 2018 Feb; 11(1):9. PubMed ID: 29439730
[TBL] [Abstract][Full Text] [Related]
29. The neuroprotective effect of a novel agent N2 on rat cerebral ischemia associated with the activation of PI3K/Akt signaling pathway.
Huang J; Kodithuwakku ND; He W; Zhou Y; Fan W; Fang W; He G; Wu Q; Chu S; Li Y
Neuropharmacology; 2015 Aug; 95():12-21. PubMed ID: 25725335
[TBL] [Abstract][Full Text] [Related]
30. MRS of brain metabolite levels demonstrates the ability of scavenging of excess brain glutamate to protect against nerve agent induced seizures.
Ruban A; Biton IE; Markovich A; Mirelman D
Int J Mol Sci; 2015 Feb; 16(2):3226-36. PubMed ID: 25648322
[TBL] [Abstract][Full Text] [Related]
31. Inducible glutamate oxaloacetate transaminase as a therapeutic target against ischemic stroke.
Khanna S; Briggs Z; Rink C
Antioxid Redox Signal; 2015 Jan; 22(2):175-86. PubMed ID: 25343301
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
33. Emulsified Isoflurane Protects Against Transient Focal Cerebral Ischemia Injury in Rats via the PI3K/Akt Signaling Pathway.
Zhang H; Xiong X; Liu J; Gu L; Li F; Wan Y; Xu S
Anesth Analg; 2016 May; 122(5):1377-84. PubMed ID: 26859875
[TBL] [Abstract][Full Text] [Related]
34. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
Li Q; Stephenson D
Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase and their blood glutamate-lowering activity in naïve rats.
Boyko M; Stepensky D; Gruenbaum BF; Gruenbaum SE; Melamed I; Ohayon S; Glazer M; Shapira Y; Zlotnik A
Neurochem Res; 2012 Oct; 37(10):2198-205. PubMed ID: 22846966
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotection of the leaf and stem of Vitis amurensis and their active compounds against ischemic brain damage in rats and excitotoxicity in cultured neurons.
Kim JY; Jeong HY; Lee HK; Kim S; Hwang BY; Bae K; Seong YH
Phytomedicine; 2012 Jan; 19(2):150-9. PubMed ID: 21778042
[TBL] [Abstract][Full Text] [Related]
37. Continuous oral administration of atorvastatin ameliorates brain damage after transient focal ischemia in rats.
Saito T; Nito C; Ueda M; Inaba T; Kamiya F; Muraga K; Katsura K; Katayama Y
Life Sci; 2014 Jan; 94(2):106-14. PubMed ID: 24333133
[TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal delivery of acetate-encapsulated liposomal nanoparticles for neuroprotection of the penumbra in a rat model of ischemic stroke.
So PW; Ekonomou A; Galley K; Brody L; Sahuri-Arisoylu M; Rattray I; Cash D; Bell JD
Int J Nanomedicine; 2019; 14():1979-1991. PubMed ID: 30936698
[TBL] [Abstract][Full Text] [Related]
39. A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo.
Nuñez-Figueredo Y; Ramírez-Sánchez J; Hansel G; Simões Pires EN; Merino N; Valdes O; Delgado-Hernández R; Parra AL; Ochoa-Rodríguez E; Verdecia-Reyes Y; Salbego C; Costa SL; Souza DO; Pardo-Andreu GL
Neuropharmacology; 2014 Oct; 85():517-27. PubMed ID: 24953828
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Citicoline Delivered via Brain Extracellular Space against Experimental Acute Ischemic Stroke in Rats.
Zhao G; Chen H; Yan J; Tong Z; Fu Y; Xie Z; Han H
Int J Med Sci; 2024; 21(7):1274-1279. PubMed ID: 38818467
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
